GSK.UK GLAXOSMITHKLINE
Trading 06-04 13:52:00 BST Delay
1,624.00
+26.00
+1.63%
High1,624.00Low1,588.00Vol2.09M
Open1,595.00D1 Closing1,598.00Amplitude2.25%
Mkt Cap6.62TTradable Cap6.40TTotal Shares4.08B
T/O3.36BT/O Rate0.05%Tradable Shares3.94B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
GlaxoSmithKline (GSK) Gets a Buy from Jefferies
TIPRANKS  ·  20:06
GlaxoSmithKline (GSK) Gets a Buy from Jefferies
GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated Multiple Myeloma
Benzinga  ·  05:08
GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated Multiple Myeloma
GSK says new data buoys Jemperli as a treatment for rectal cancer
seekingalpha  ·  01:20
GSK says new data buoys Jemperli as a treatment for rectal cancer
Wall Street Lunch: New AI Chips Are Here
seekingalpha  ·  00:50
Wall Street Lunch: New AI Chips Are Here
Top Midday Stories: NYSE Resolves Technical Issues; Paramount, Skydance Agree to Merger Terms; Waste Management to Acquire Stericycle; GameStop Soars on 'Roaring Kitty' Stake Purchase
MT Newswires Live  ·  00:30
Top Midday Stories: NYSE Resolves Technical Issues; Paramount, Skydance Agree to Merger Terms; Waste Management to Acquire Stericycle; GameStop Soars on 'Roaring Kitty' Stake Purchase
GSK says Blenrep combo cuts disease progression, death in multiple myeloma
seekingalpha  ·  00:03
GSK says Blenrep combo cuts disease progression, death in multiple myeloma
Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move Forward
Benzinga  ·  06-03 23:53
Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move Forward
GSK Stock Dips on Delaware Court Ruling for Zantac Litigation
Zacks  ·  06-03 23:40
GSK Stock Dips on Delaware Court Ruling for Zantac Litigation
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading
MT Newswires Live  ·  06-03 23:03
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading
GSK Reports Share Capital and Voting Rights
TIPRANKS  ·  06-03 22:31
GSK Reports Share Capital and Voting Rights
Trending: GSK Shares Tumble on Zantac's Legal Setback
Dow Jones  ·  06-03 21:12
Trending: GSK Shares Tumble on Zantac's Legal Setback
Sector Update: Health Care Stocks Steady Premarket Monday
MT Newswires Live  ·  06-03 21:10
Sector Update: Health Care Stocks Steady Premarket Monday
GSK Says Cancer Drug Jemperli Shows 100% Clinical Response Rate in Long-Term Data From Mid-Stage Trial
MT Newswires Live  ·  06-03 20:59
GSK Says Cancer Drug Jemperli Shows 100% Clinical Response Rate in Long-Term Data From Mid-Stage Trial
GSK's Zantac Ruling Is a Surprise, But Should Have Limited Effect -- Market Talk
Dow Jones  ·  06-03 20:35
GSK's Zantac Ruling Is a Surprise, But Should Have Limited Effect -- Market Talk
GSK’s Jemperli Shows Remarkable Trial Results
TIPRANKS  ·  06-03 20:17
GSK’s Jemperli Shows Remarkable Trial Results
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer
Business Wire  ·  06-03 20:10
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer
GSK: How much could the Zantac lawsuits cost?
cityam  ·  06-03 19:57
GSK: How much could the Zantac lawsuits cost?
GSK (NYSE:GSK) Nosedives Amid Zantac Lawsuits Tsunami
TIPRANKS  ·  06-03 19:51
GSK (NYSE:GSK) Nosedives Amid Zantac Lawsuits Tsunami
GSK's Zantac Setback Could Cost $3Bln, Citi Says -- Market Talk
Dow Jones  ·  06-03 19:49
GSK's Zantac Setback Could Cost $3Bln, Citi Says -- Market Talk
GSK stock plunges after 75,000 Zantac cases allowed to move forward
seekingalpha  ·  06-03 19:25
GSK stock plunges after 75,000 Zantac cases allowed to move forward

Introduction

Company Name.
GLAXOSMITHKLINE
Affiliated Markets:
LSE
Listing Date:
--
Main Business:
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.
Issue price:
--